Call for Papers  

Article Details

Review Article

Drug Delivery for Ocular Allergy: Current Formulation Design Strategies and Future Perspectives

[ Vol. 29 , Issue. 33 ]


Varaprasada Rao Regu, Ranjit Prasad Swain and Bharat Bhusan Subudhi*   Pages 2626 - 2639 ( 14 )


The incidences of ocular allergy have been growing with the increase in pollution. Because of challenges in new drug development, there have been efforts to maximize the efficacy of existing drugs through drug delivery approaches. The effectiveness of drugs in ophthalmic conditions is primarily determined by permeability across the barrier, corneal retention, and sustained release. Thus, there have been widespread efforts to optimize these parameters to enhance efficacy through novel formulations. This review aims to analyze the approaches to drug delivery systems to encourage further research to optimize effectiveness. With this objective, research on drug delivery aspects of anti-allergy therapeutics was included and analyzed based on formulation/drug delivery technique, Food and Drug Administration approval limits, residence time, compatibility, pre-clinical efficacy, and potential for translational application. Conventional eye drops have concerns such as poor residence time and ocular bioavailability. The novel formulations have the potential to improve residence and bioavailability. However, the use of preservatives and the lack of regulatory approval for polymers limit the translational application. The review may assist readers in identifying novel drug delivery strategies and their limitations for the development of effective ophthalmic formulations for the treatment of ocular allergy.


Ocular allergy, ocular inflammation, conjunctivitis, ocular drug delivery, translational application, novel formulations.


Read Full-Text article